Company / EPS (Diluted)
CAPRICOR THERAPEUTICS, INC. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.26
FY2025
5-year range
-$2.26 / -$0.83
FY2021-FY2025
Trend
-96.5%
vs FY2024
Sector context
#134 of 204
Health Care
What the data says
At $-2.26, CAPRICOR THERAPEUTICS, INC.'s eps (diluted) ranks #134 of 204 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $-5.17 in FY2019 to $0.09 in FY2017.
Based on SEC 10-K filings.
-2.26 in FY2025.
Declined from $-0.83 to $-2.26 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#134 of 204 in Health CareTop 66% of 204This company -$2.26 Sector average -$1.30
▼
-73.4% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 96.5% year-over-year.
- Ranks #134 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2017.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.26 | -96.5% |
| FY2024 | -$1.15 | -38.6% |
| FY2023 | -$0.83 | +29.7% |
| FY2022 | -$1.18 | -35.6% |
| FY2021 | -$0.87 | +1.1% |
| FY2020 | -$0.88 | +83.0% |
| FY2019 | -$5.17 | -894.2% |
| FY2018 | -$0.52 | -677.8% |
| FY2017 | $0.09 | +108.9% |
| FY2016 | -$1.01 | -24.7% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026